Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 15.3 Cr.
- Current Price ₹ 4.78
- High / Low ₹ 29.0 / 3.86
- Stock P/E 5.57
- Book Value ₹ 14.0
- Dividend Yield 0.00 %
- ROCE 5.04 %
- ROE 13.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.34 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -14.0%
- Working capital days have increased from 106 days to 153 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.02 | 0.01 | 0.44 | 0.27 | 0.23 | 0.00 | 5.20 | 2.48 | 9.00 | 9.29 | 9.45 | 6.01 | |
0.21 | 0.17 | 1.34 | 0.59 | 0.38 | 0.24 | 2.45 | 5.25 | 2.75 | 8.94 | 9.02 | 8.93 | 2.77 | |
Operating Profit | -0.11 | -0.15 | -1.33 | -0.15 | -0.11 | -0.01 | -2.45 | -0.05 | -0.27 | 0.06 | 0.27 | 0.52 | 3.24 |
OPM % | -110.00% | -750.00% | -13,300.00% | -34.09% | -40.74% | -4.35% | -0.96% | -10.89% | 0.67% | 2.91% | 5.50% | 53.91% | |
-1.03 | 0.01 | 1.35 | -0.01 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -1.15 | -0.15 | 0.02 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.06 | 0.29 | 0.52 | 3.24 |
Tax % | 0.00% | 0.00% | -450.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | -3.45% | 0.00% | |
-1.15 | -0.15 | 0.11 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.04 | 0.30 | 0.52 | 2.75 | |
EPS in Rs | -0.48 | -0.06 | 0.05 | -0.07 | -0.05 | -0.00 | -0.99 | -0.02 | -0.11 | 0.02 | 0.12 | 0.16 | 0.87 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 85% |
5 Years: | % |
3 Years: | 56% |
TTM: | -46% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 17% |
3 Years: | 58% |
TTM: | 366% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 38% |
3 Years: | 31% |
1 Year: | -77% |
Return on Equity | |
---|---|
10 Years: | -14% |
5 Years: | 7% |
3 Years: | 14% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.66 | 12.01 | 32.02 |
Reserves | -5.37 | -5.52 | -5.41 | -5.58 | -5.68 | -5.69 | -8.08 | -8.12 | -8.39 | -8.35 | -7.75 | -6.05 | 12.74 |
0.20 | 0.33 | 0.01 | 0.35 | 0.01 | 0.06 | 0.00 | 0.02 | 0.24 | 1.72 | 1.86 | 10.91 | 1.04 | |
0.60 | 0.62 | 0.51 | 0.55 | 0.52 | 0.53 | 0.02 | 5.15 | 2.57 | 2.27 | 3.14 | 0.02 | 4.63 | |
Total Liabilities | 4.49 | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 50.43 |
0.09 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.84 | 1.84 | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
2.56 | 2.57 | 4.08 | 4.30 | 3.83 | 3.88 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 50.43 | |
Total Assets | 4.49 | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 50.43 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.07 | -0.12 | -3.49 | 0.25 | 0.07 | 0.04 | -0.40 | 0.13 | -0.31 | -1.51 | -0.15 | -13.46 | |
0.00 | -0.01 | 4.17 | -0.40 | -0.29 | -0.09 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.07 | 0.13 | -0.32 | 0.35 | -0.34 | 0.05 | -0.55 | 0.02 | 0.22 | 1.48 | 1.04 | 12.58 | |
Net Cash Flow | 0.00 | 0.00 | 0.35 | 0.20 | -0.56 | 0.00 | -0.03 | 0.15 | -0.09 | -0.03 | 0.88 | -0.88 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 0.00 | 16.59 | 27.04 | 0.00 | 365.00 | 390.02 | 158.57 | 200.77 | 132.87 | |
Inventory Days | 861.89 | 2,199.12 | 4,051.50 | 13.52 | 28.19 | 8.01 | 7.85 | 16.95 | ||||
Days Payable | 0.00 | 0.00 | 0.00 | 365.00 | 378.35 | 94.41 | 128.97 | 0.00 | ||||
Cash Conversion Cycle | 0.00 | 0.00 | 861.89 | 2,215.72 | 4,078.54 | 0.00 | 13.52 | 39.86 | 72.17 | 79.65 | 149.81 | |
Working Capital Days | -36.50 | -730.00 | 101,835.00 | 1,982.61 | 2,987.59 | 3,427.83 | 18.25 | 44.15 | 75.43 | 90.76 | 152.57 | |
ROCE % | -2.03% | -3.87% | -34.79% | -4.01% | -3.05% | -0.29% | -110.66% | -5.15% | -28.88% | 3.59% | 9.35% | 5.04% |
Documents
Announcements
- Closure of Trading Window 29 Mar
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
25 Mar - Intimation of duplicate share certificates issuance.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
18 Feb - News Paper Advertisement for Unaudited Financial Result for the quarter ended 31st December, 2024
-
Integrated Filing (Financial)
14 Feb - Integrated financial filing for Q4 2024.
-
Unaudited Standalone And Consolidated Financial Result For The Quarter Ended December 31, 2024
14 Feb - Board approved Q3 financial results for 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector